-
Adagrasib,ADADX,Adagrasib,200mg
Regular price ¥3,300.00 CNYRegular priceUnit price per¥5,800.00 CNYSale price ¥3,300.00 CNYSale -
Adalacilib is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have received at least one prior systemic therapy.
Regular price ¥3,300.00 CNYRegular priceUnit price per¥6,000.00 CNYSale price ¥3,300.00 CNYSale -
Sotorasib, SOTOLDX, Sotorasib 120mg
Regular price ¥1,470.00 CNYRegular priceUnit price per¥2,800.00 CNYSale price ¥1,470.00 CNYSale -
Sotoraib Sotorasib 120mg 120 tablets Approval No. 07 L 0986/23 Expiry Date 03-7-2026
Regular price ¥2,800.00 CNYRegular priceUnit price per¥5,000.00 CNYSale price ¥2,800.00 CNYSale -
Sotolacizumab is indicated for the treatment of adult patients with KRAS G12C mutant locally advanced or metastatic non-small cell lung cancer who have received at least one prior systemic therapy.
Regular price ¥1,700.00 CNYRegular priceUnit price per¥2,800.00 CNYSale price ¥1,700.00 CNYSale -
SOTORASIB 120MG 56 tablets Approval No. 03 L 0903/22 Valid until 02-3-2025
Regular price ¥1,500.00 CNYRegular priceUnit price per¥3,000.00 CNYSale price ¥1,500.00 CNYSale -
SOTORMAKS Laos State-owned Plant No. 2 sotorasib 120mg 112tables
Regular price ¥2,900.00 CNYRegular priceUnit price per
